Description

CJC-1295 5mg (No DAC) + Ipamorelin  | Growth Hormone Signaling Blend 10mg | Laboratory Research Compound | Mile High Peptides LLC

Commonly Researched For:

• Growth hormone signaling and release

• Body composition and metabolic models

• Performance, recovery, and resilience research

Description

This blend combines CJC-1295 (No DAC) with Ipamorelin into a single 10mg vial, giving researchers two complementary growth hormone–related peptides in one convenient format. CJC-1295 (No DAC) is often studied for its GHRH-style signaling, while Ipamorelin is commonly explored as a selective growth hormone secretagogue.

Researchers frequently use this combination in in‑vitro models that look at growth hormone release patterns, metabolic changes, and performance or recovery-related endpoints. The blend allows them to investigate how stimulating GH pathways from two angles may influence downstream markers tied to body composition and resilience.

Mile High Peptides LLC supplies this compound for research and educational purposes.

Product Details

• Total compound: 10mg
• Lyophilized powder format
• Laboratory research use only
• Intended for analytical and in-vitro research applications

Important Notice

• For laboratory research and educational purposes only
• Not for human consumption
• Not for medical, cosmetic, or therapeutic use
• Not intended to diagnose, treat, cure, or prevent any disease
• Observations and research outcomes may vary based on handling, storage, environment, methodology, and study conditions
• Materials supplied are not finished consumer products

Mile High Peptides LLC supplies materials strictly for in-vitro laboratory research and analytical applications by qualified research professionals.